Table 2 Hazard ratios (95% confidence intervals) for incident outcomes after incident breast cancer.
Outcome* | No. of cases (incidence rate per 100,000 person-years) | Hazard ratio (95% CI) | ||
|---|---|---|---|---|
No breast cancer | Incident breast cancer | Crude | Adjusted | |
Leukemia (N = 1,142,643) | 716 (6.7) | 129 (30.4) | 4.19 (3.47, 5.05) | 4.20 (3.48, 5.07) |
Cardiomyopathy (N = 1,142,076) | 957 (9.0) | 143 (33.7) | 3.20 (2.68, 3.82) | 3.28 (2.75, 3.91) |
Osteoporosis (N = 1,070,659) | 74,818 (789.9) | 8374 (2658.1) | 2.97 (2.91, 3.04) | 3.00 (2.93, 3.07) |
Endometrial cancer (N = 1,142,643) | 1539 (14.5) | 178 (42.0) | 2.69 (2.30, 3.14) | 2.70 (2.31, 3.16) |
Hypothyroidism (N = 1,122,284) | 43,119 (420.2) | 2894 (724.0) | 1.68 (1.62, 1.74) | 1.69 (1.63, 1.76) |
Pulmonary fibrosis (N = 1,142,493) | 599 (5.6) | 44 (10.4) | 1.60 (1.18, 2.17) | 1.62 (1.19, 2.20) |
Myeloma (N = 1,142,643) | 434 (4.1) | 31 (7.3) | 1.53 (1.06, 2.20) | 1.54 (1.07, 2.22) |
Hyperlipidemia (N = 1,054,439) | 292,404 (3452.5) | 15,691 (5240.3) | 1.34 (1.32, 1.37) | 1.37 (1.35, 1.39) |
End-stage renal disease (N = 1,141,344) | 1823 (17.1) | 86 (20.3) | 1.03 (0.83, 1.28) | 1.13 (0.91, 1.40) |
Type 2 diabetes (N = 1,070,608) | 104,448 (1102.2) | 4927 (1358.7) | 1.10 (1.07, 1.13) | 1.13 (1.10, 1.16) |
Hypertension (N = 974,915) | 193,966 (2425.0) | 5049 (1648.8) | 0.60 (0.58, 0.62) | 0.61 (0.59, 0.63) |